Management of Diabetes Mellitus Patients With Retinopathy

August 17, 2010 updated by: AstraZeneca

Aim of this NIS is to retrospectively document the management of diabetic patients with retinopathy in a naturalistic setting in Switzerland. Following elements are going to be analyzed:

  • which medication are used to keep blood pressure under control?
  • which medication are used for metabolic control?
  • the average control level of metabolism and blood pressure is compliant with the international guidelines?
  • laser photocoagulation plays a role in the control of metabolism and blood pressure?
  • there are differences in the control of metabolism and blood pressure between patients with DM I or DM II?
  • there is an influence of renal failure on the choose of medication?

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Anticipated)

2500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
    • AG
      • Dattwil, AG, Switzerland
        • Research Site
      • Hausen b. Brugg, AG, Switzerland
        • Research Site
      • Lenzburg, AG, Switzerland
        • Research Site
      • Lupfig, AG, Switzerland
        • Research Site
      • Muri AG, AG, Switzerland
        • Research Site
      • Rheinfelden, AG, Switzerland
        • Research Site
      • Schinznach Dorf, AG, Switzerland
        • Research Site
      • Spreitenbach, AG, Switzerland
        • Research Site
    • BE
      • Bern, BE, Switzerland
        • Research Site
      • Moutier, BE, Switzerland
        • Research Site
      • Unterseen, BE, Switzerland
        • Research Site
    • BL
      • Diegten, BL, Switzerland
        • Research Site
      • Laufen, BL, Switzerland
        • Research Site
    • BS
      • Basel, BS, Switzerland
        • Research Site
    • FR
      • Estavayer-le-Lac, FR, Switzerland
        • Research Site
      • Fribourg, FR, Switzerland
        • Research Site
    • GE
      • Collonge-Bellerive, GE, Switzerland
        • Research Site
      • Geneve, GE, Switzerland
        • Research Site
      • Le Grand-Saconnex, GE, Switzerland
        • Research Site
      • Les Acacias, GE, Switzerland
        • Research Site
      • Versoix, GE, Switzerland
        • Research Site
    • GR
      • Chur, GR, Switzerland
        • Research Site
      • Ilanz, GR, Switzerland
        • Research Site
      • Samedan, GR, Switzerland
        • Research Site
    • JU
      • Alle, JU, Switzerland
        • Research Site
    • LU
      • Luzern, LU, Switzerland
        • Research Site
      • Rothenburg, LU, Switzerland
        • Research Site
    • NE
      • Le Locle, NE, Switzerland
        • Research Site
    • OW
      • Kerns, OW, Switzerland
        • Research Site
    • SG
      • Oberuzwil, SG, Switzerland
        • Research Site
      • Rorschach, SG, Switzerland
        • Research Site
      • St. Gallen, SG, Switzerland
        • Research Site
      • Wangs, SG, Switzerland
        • Research Site
    • SH
      • Schaffhausen, SH, Switzerland
        • Research Site
    • SZ
      • Kussnacht am Rigi, SZ, Switzerland
        • Research Site
      • Tuggen, SZ, Switzerland
        • Research Site
    • TG
      • Kreuzlingen, TG, Switzerland
        • Research Site
    • TI
      • Ascona, TI, Switzerland
        • Research Site
      • Locarno, TI, Switzerland
        • Research Site
      • Lugano, TI, Switzerland
        • Research Site
      • Viganello, TI, Switzerland
        • Research Site
    • VD
      • Aigle, VD, Switzerland
        • Research Site
      • Bassins, VD, Switzerland
        • Research Site
      • Bex, VD, Switzerland
        • Research Site
      • Chateau-d'Oex, VD, Switzerland
        • Research Site
      • Clarens, VD, Switzerland
        • Research Site
      • Eysins, VD, Switzerland
        • Research Site
      • Lausanne, VD, Switzerland
        • Research Site
      • Nyon, VD, Switzerland
        • Research Site
      • Prilly, VD, Switzerland
        • Research Site
      • Renens VD, VD, Switzerland
        • Research Site
      • Salavaux, VD, Switzerland
        • Research Site
      • St-Legier, VD, Switzerland
        • Research Site
      • Vevey, VD, Switzerland
        • Research Site
    • VS
      • Ardon, VS, Switzerland
        • Research Site
      • Evionnaz, VS, Switzerland
        • Research Site
      • Saviese, VS, Switzerland
        • Research Site
      • Sierre, VS, Switzerland
        • Research Site
      • Sion, VS, Switzerland
        • Research Site
    • ZH
      • Bassersdorf, ZH, Switzerland
        • Research Site
      • Egg b. Zurich, ZH, Switzerland
        • Research Site
      • Winterthur, ZH, Switzerland
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Diabetic patients with diabetic retinopathy

Description

Inclusion Criteria:

  • Diabetic patients
  • Diabetic retinopathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
1
Diabetic patients with retinopathy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Blood lipids, glycemia, HbA1C, blood creatinine, proteinuria, body weight
Time Frame: every 3 months
every 3 months
evolution of diabetic retinopathy
Time Frame: every 3 months
every 3 months

Secondary Outcome Measures

Outcome Measure
Time Frame
concomitant medication
Time Frame: every 3 months
every 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AstraZeneca

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2008

Study Completion (Actual)

August 1, 2009

Study Registration Dates

First Submitted

January 23, 2009

First Submitted That Met QC Criteria

January 23, 2009

First Posted (Estimate)

January 26, 2009

Study Record Updates

Last Update Posted (Estimate)

August 18, 2010

Last Update Submitted That Met QC Criteria

August 17, 2010

Last Verified

August 1, 2010

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NIS-CCH-DUM-2008/1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe